Physician profile
Nicole A Hubbard
NPI 1063675882
$14,636.39
in general payments reported to CMS, 2019-2025
11 companies · $116 in 2025
The $116 reported for 2025 was more than what a typical Clinical Pathology provider received nationally (typical 2025 total: $116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $1,000 · 2021: $10.50 · 2023: $3,185 · 2024: $116 · 2025: $116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,040 · Food and Beverage: $377.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,040.00 |
| Food and Beverage | $377.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $6,761.15 | 2019-2023 | |
| Biofire Diagnostics, LLC | $5,028.06 | 2019-2020 | |
| Quidel Corporation | $2,270.55 | 2019 | |
| Beckman Coulter, INC. | $333.70 | 2019-2025 | Microscan |
| Ortho-Clinical Diagnostics, INC. | $115.96 | 2024 | |
| Cepheid | $41.42 | 2025 | Genexpert |
| Roche Diagnostics Corporation | $28.26 | 2019 | |
| Abbott Laboratories | $15.73 | 2023 | Cardiomems |
| Allergan, INC. | $15.29 | 2019 | |
| Siemens Medical Solutions USA, INC. | $13.35 | 2019 | |
| Merck Sharp & Dohme LLC | $12.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Hubbard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.